Location History:
- US (2000)
- Nova Scotia, GB (2001)
- Nova Scotia, CA (2003)
Company Filing History:
2 out of 34 
1 out of 832,912 Years Active: 2000-2003
Title: The Innovative Contributions of Peter Redden
Introduction
Peter Redden is a notable inventor based in California, recognized for his significant contributions to the field of drug delivery systems. With a total of three patents to his name, Redden has made strides in developing bioactive compounds that have potential therapeutic applications.
Latest Patents
Among his latest patents, Redden has focused on 1,3-propane diol esters and ethers, along with methods for their use in drug delivery. He has also worked on fatty acid esters as bioactive compounds, specifically compounds of structure (I). These compounds are designed for therapeutic use, where R represents an acyl group derived from a C fatty acid with two or more cis or trans double bonds, particularly from the n-6 or n-3 series of essential fatty acids or conjugated linoleic acid, columbinic acid, or parinaric acid. The versatility of R allows for various nutrients, drugs, or other bioactive residues to be released as active components in the body.
Career Highlights
Throughout his career, Redden has been associated with Scotia Holdings Plc, where he has contributed to innovative projects and research. His work has focused on enhancing drug delivery mechanisms, which are crucial for improving therapeutic outcomes.
Collaborations
Peter Redden has collaborated with notable individuals in his field, including David F. Horrobin and Mehar S. Manku. These collaborations have further enriched his research and development efforts.
Conclusion
Peter Redden's innovative work in drug delivery systems and bioactive compounds highlights his significant role as an inventor. His contributions continue to influence the field and pave the way for future advancements in therapeutic applications.